Further, we performed differential correlation analysis, which indicated TXNDC9 in lineage-dependent roles that had opposing correlations to chemosensitivity, and which could be further explored to understand the response to therapy in childhood ALL and lineage-linked biological differences. This evidence concerns the gene TXNDC9 and acute lymphoblastic leukemia.